Age-Related Macular Degeneration

Age-Related Macular Degeneration Dr Charlotte Hazel

Introduction ,[object Object],[object Object],[object Object],[object Object],[object Object]

Anatomy ,[object Object],[object Object],[object Object],[object Object],[object Object]

Anatomy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Definitions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pathophysiology ,[object Object],[object Object],[object Object],[object Object]

Pathophysiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Pathophysiology Drusen Bruch’s Membrane RPE Photoreceptors Choroid

Pathophysiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Summary ,[object Object],[object Object],[object Object],[object Object]

Non-Exudative AMD ,[object Object],[object Object],[object Object],[object Object],[object Object]

Geographic Atrophy (GA) ,[object Object],[object Object],[object Object],[object Object],[object Object]

Geographic Atrophy (GA) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Exudative AMD ,[object Object],[object Object],[object Object],[object Object]

Choroidal Neovascularisation ,[object Object],[object Object],[object Object]

Choroidal Neovascularisation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Choroidal Neovascularisation ,[object Object],[object Object],[object Object],[object Object]

Choroidal Neovascularisation RPE Bruch’s Membrane Photoreceptors Choroid

Investigation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Investigation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Investigation ,[object Object],[object Object],[object Object]

Management ,[object Object],[object Object],[object Object],[object Object]

Mx. Non-exudative ,[object Object],[object Object],[object Object],[object Object],[object Object]

Mx. Non-exudative ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Mx. Exudative ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Fluorescein Angiography CNV Pre- and Post- Laser Tx CNV Pre-Laser CNV Post-Laser

Mx. Exudative ,[object Object],[object Object],[object Object],[object Object],[object Object]

Mx. Exudative ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Risk Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Prevention ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Prevention US$ 68.95 per 500ml bottle

References ,[object Object],[object Object],[object Object],[object Object],[object Object]

Empfohlen